Provectus Pharmaceuticals (PVCT)
OTHER OTC:PVCT
US Market
Holding PVCT?
Track your performance easily

Provectus Pharmaceuticals (PVCT) Income Statement

77 Followers

Provectus Pharmaceuticals Income Statement

Last quarter (Q ), Provectus Pharmaceuticals's total revenue was $254.99K, an increase of 24.37% from the same quarter last year. In Q, Provectus Pharmaceuticals's net income was $-846.85K. See Provectus Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 724.61K$ 557.71K$ 989.04K-$ 0.00$ 0.00
Cost of Revenue
------
Gross Profit
$ 724.64K$ 557.71K$ 989.04K---
Operating Expense
$ 3.48M$ 3.46M$ 4.42M$ 4.67M$ 4.93M$ 6.16M
Operating Income
$ -2.76M$ -2.90M$ -3.43M$ -4.67M$ -4.93M$ -6.16M
Net Non Operating Interest Income Expense
$ -230.42K$ -216.21K$ -163.69K$ -930.38K$ -1.74M$ -1.43M
Other Income Expense
$ -15.80K$ -15.70K$ -36.95K$ -63.09K$ -1.27K$ 674.17K
Pretax Income
$ -2.97M$ -3.10M$ -3.55M$ -5.54M$ -6.68M$ -6.92M
Tax Provision
-$ -704.63K$ 670.69K$ -367.79K--
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -2.96M$ -3.10M$ -3.55M$ -5.54M$ -6.68M$ -6.92M
Basic EPS
-$ -0.01$ -0.01$ -0.01$ -0.02$ -0.02
Diluted EPS
-$ -0.01$ -0.01$ -0.01$ -0.02$ -0.02
Basic Average Shares
$ 1.68B$ 419.51M$ 419.47M$ 408.22M$ 393.25M$ 386.59M
Diluted Average Shares
$ 1.68B$ 419.51M$ 419.47M$ 408.22M$ 393.25M$ 386.59M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
----$ 32.76K$ 37.52K
Total Expenses
$ 3.48M$ 3.46M$ 4.42M$ 4.67M$ 4.93M$ 6.16M
Net Income From Continuing And Discontinued Operation
$ -2.96M$ -3.10M$ -3.55M$ -5.54M$ -6.68M$ -6.92M
Normalized Income
$ -2.12M---$ -6.68M$ -7.60M
Interest Expense
----$ 1.75M$ 1.46M
EBIT
$ -2.73M$ -3.59M$ -2.72M$ -4.61M$ -4.93M$ -5.47M
EBITDA
$ -2.72M$ -3.58M$ -2.71M$ -4.60M$ -4.69M$ -4.78M
Currency in USD

Provectus Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis